VWF and COVID-19: In COVID-19, the ADAMTS13/vWF ratio decreases, leading to an excess of overactive UL-vWF multimers as a key driver of microthromboses in the pulmonary vasculature and SARS-CoV-2-associated ARDS [11,95,111,116,117,118,119].